Global leader in tau-based research in Alzheimer’s disease (AD)
TauRx Pharmaceuticals has raised €115M across 1 funding round, most recently a round in Nov 2022. Based in Aberdeen, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-14 | Other | €115M |
| — |
| View deal → |
